Tehran University of Medical Sciences

Science Communicator Platform

Share By
Peptide and Protein Vaccines for Cancer Publisher



Keshavarzfathi M1, 2, 3 ; Rezaei N3, 4, 5
Authors

Source: Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Published:2019


Abstract

Tumor antigens are the basis of most cancer vaccine strategies and other types of specific cancer immunotherapy. They are targeted by application of various approaches, and using the peptides containing the epitope(s) of a tumor antigen benefits form an standard and easy method to evoke anticancer immunity. However, some drawbacks are attributed to this simple method, which limit its usage unless optimization is undertaken. In this chapter, peptide- and protein-based vaccines against many types of cancer will be reviewed. Results of the clinical trials, advantages and disadvantages, and some suggestions to optimize peptide-based vaccine toward its pervasive usage will be provided. © 2019 Nima Rezaei and Mahsa Keshavarz-Fathi Published by Elsevier Ltd. All rights reserved.
Related Docs
View other Related Docs
1. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
2. A Novel Recombinant Anti-Epidermal Growth Factor Receptor Peptide Vaccine Capable of Active Immunization and Reduction of Tumor Volume in a Mouse Model, Microbiology and Immunology (2017)
3. Dna Vaccines As Promising Immuno-Therapeutics Against Cancer: A New Insight, Frontiers in Immunology (2024)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (6)
Mohammad Hossein Modarressi (2)
Other Related Docs
4. Combining Anti-Checkpoint Immunotherapies and Cancer Vaccines As a Novel Strategy in Oncological Therapy: A Review, Human Immunology (2025)
5. Vaccination and Personalized Cancer Vaccines Focusing on Common Cancers in Women: A Narrative Review, Pathology, research and practice (2025)
6. Lung Cancer Vaccine Strategies: Exploring the Spectrum From Traditional to Rna-Based Platforms, Frontiers in Bioengineering and Biotechnology (2025)
7. Whole Tumor Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
8. Obstacles in the Development of Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
9. Whole Tumor Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
10. Obstacles in the Development of Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
11. Mrna Cancer Vaccines From Bench to Bedside: A New Era in Cancer Immunotherapy, Biomarker Research (2024)
12. Hpv16-E7 Protein T Cell Epitope Prediction and Global Therapeutic Peptide Vaccine Design Based on Human Leukocyte Antigen Frequency: An In-Silico Study, International Journal of Peptide Research and Therapeutics (2021)
13. Immune Cell Vaccine For Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
14. Immune Cell Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
15. The Role of Peptide-Based Tumor Vaccines on Cytokines of Adaptive Immunity: A Review, International Journal of Peptide Research and Therapeutics (2021)
16. Plant-Based Vaccines and Cancer Therapy: Where Are We Now and Where Are We Going?, Pharmacological Research (2021)
17. Nanovaccines for Cancer Immunotherapy: Focusing on Complex Formation Between Adjuvant and Antigen, International Immunopharmacology (2023)
18. Gene Therapy and Genetic Vaccines, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
19. Vaccination With Human Amniotic Epithelial Cells Confer Effective Protection in a Murine Model of Colon Adenocarcinoma, International Journal of Cancer (2018)
20. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)